Issue # 150 – Portfolio’s launches Fund IV, Google AI Health Coach, 90-Day Market-Access Blueprint to scale

✨Hey there! You’re reading the free edition of the FemTech India newsletter — your go-to source for the latest in women’s health, industry updates, and opportunities to help you navigate what’s next in your journey.

In FemTech & digital health, $8B–$60B+ markets are growing  fast but only ~30% of AI/digital health pilots reach production. Regulatory delays, poor retention, and unclear ROI kill most launches. 

That’s why we created the 90-Day Traction Market-Access Sprint, a proven blueprint to convert pilots into paid contracts.

Trusted by startups and enterprises across Asia, UK & USA, this framework helps FemTech, consumer health, and digital therapeutics teams secure partnerships, procurement, and scale faster.

Access here  ,and I’ll send you a customized one-pager tailored to your business.

• Google launches AI-powered FitBit health coach, built on Gemini model, previewing in October for Premium users on new trackers and Pixel Watches.
• Samsung India, with NeuroLogica, introduces next-generation mobile CT solutions, expanding advanced imaging access across hospitals nationwide.

• Portfolio has launched Women’s Health Fund IV with its first investment in biotech startup Gameto, part of the company’s $44M Series C, reinforcing its focus on women’s health innovation.
• Bengaluru-based medtech startup Cureous Labs has raised ₹16.6 cr in a seed funding round led by Inflection Point Ventures (IPV), with participation from Anthill Ventures.
• Mid-Atlantic Biotherapeutics, a Doylestown, PA-based biotech company developing therapies for neurological disorders, received up to $50M from Legend Innovation Life Science Fund.
• EnsiliTech, a Bristol, UK-based biotechnology startup, raised £4.5M in Seed funding.
• Wugen, a St. Louis, MO-based clinical-stage biotechnology company, raised $115M in funding.
• EliseAI has raised $250 million in Series E funding led by Andreessen Horowitz to expand its healthcare automation platform. The round includes participation from Bessemer Venture Partners

• Kerala startup Mykare Health launches Daily Health Savings App, tackling affordability and access challenges for India’s middle-class population.
• IIT Roorkee Collaborates with UnivLabs for Advancing Urology Healthcare. 
• Firms will be asked to provide flexible working for menopausal women under Labour’s workplace reforms, aimed at improving retention and boosting the economy. Ministers believe letting female staff experiencing symptoms work from home or adjust hours will help them stay in jobs longer, while helping businesses retain skilled workers.
• The Medicines and Healthcare products Regulatory Agency (MHRA) has approved gepotidacin (Blujepa), a new kind of oral antibiotic pill to treat uncomplicated urinary tract infections (UTIs) in females aged 12 years and older, weighing at least 40 kg. 
• Researchers from Kumamoto University have identified a distinctive CT imaging pattern that can predict which women experiencing severe postpartum hemorrhage (PPH) are most likely to need life-saving interventions.
• Genetic testing of IVF-created embryos could help more women over 35 have a baby in less time, a clinical trial by researchers from King’s College London, King’s College Hospital, and King’s Fertility has found.
• Researchers at the University of Warwick have developed a new diamond-based sensor that they said could be a “game-changer” in detecting the spread of tumours. The team said the new non-toxic and non-radioactive device was “ultra sensitive” and used the “unique properties of diamonds to diagnose metastasised breast cancer”.
• Researchers behind a new study into phantom limb pain believe it could change how the phenomenon is treated. The universities of Cambridge and Pittsburgh followed three people due to have one of their hands amputated. Phantom limb pain is experienced as a sensation or itch seemingly coming from the limb that is no longer there.
• Allergic reactions to foods such as pine nuts and goat’s milk happen frequently enough they may need warning labels, say experts. Food packaging in the UK and EU already lists the most common allergens for people to be aware of, such as egg, peanuts and sesame.
• The FDA approved updated COVID-19 shots with restrictions for many adults and children. The FDA will limit COVID-19 vaccinations to “high risk” younger adults and children with at least one chronic health condition like obesity or asthma. In addition, children under 5 will no longer have access to Pfizer’s COVID-19 vaccine, but will be eligible for shots from Moderna and Novavax.
• Ultra-processed foods (UPFs) have developed an unhealthy reputation, but not all UPFs are created equally. A new scientific advisory from the American Heart Association (AHA) has challenged the idea that all ultra-processed foods are unhealthy

• eIVF, a portfolio company of Atlantic Street Capital (ASC), announced the launch of eIVF CloudFlex, a fully hosted, cloud-based solution that brings the full capabilities of eIVF’s unified platform to fertility clinics.
• AI-powered data company Tempus AI announced it will acquire Paige, an AI-enabled diagnostic platform for oncologists and pathologists, for $81.25 million. The acquisition is expected to expand Tempus’ technical team and establish a stronger presence in digital pathology.
• Japan’s Terumo will acquire U.K.-based OrganOx in a deal valued at about $1.5 billion, marking the Tokyo-based medical device company’s entry into the transplantation sector. OrganOx manufactures a liver perfusion system that supplies oxygenated blood, medications, and nutrients to donor organs at near body temperature. The device also enables functional assessment to support transplant decisions.
• CitiusTech has acquired Health Data Movers, a US-based healthcare technology services firm, to enhance integration capabilities across Epic, Workday, ServiceNow, and other core healthcare platforms. The acquisition is aimed at helping healthcare providers unify complex technology ecosystems and improve clinical workflows.
• GSK has announced the availability of its much-awaited advanced therapies Jemperli (dostarlimab) and Zejula (niraparib) in India, marking its commitment to addressing the unmet need for specialised treatments in cancer care.

Save the date and join the 2025 Tech4Eva Conference on December 4th!

Be where Femtech disruption happens! The thing about Femtech is that it’s revolutionary. Some of the

solutions coming to market are total game-changers for women around the world. And like any start-up,building a product takes time and patience. Hear from experts and innovators what it takes to launch a Femtech start-up.

Register Here

• The Andhra Pradesh government has launched the Bharat Biodesign Research and Innovation (BRAIN) programme at the Ratan Tata Innovation Hub (RTIH), Amaravati, to accelerate AI-driven affordable healthcare solutions and medtech innovation.
• Union Minister of Health and Family Welfare JP Nadda has launched ‘Ayushman Sakhi’, a smart chatbot designed to enhance citizen services under national health schemes.
• Union Health Minister Jagat Prakash Nadda has announced a series of centrally sponsored health programmes in Madhya Pradesh aimed at strengthening public health and expanding community outreach.

📳 – Quick Reads: 

• Is your intermittent fasting routine dangerous? What experts say. Intermittent fasting, despite its popularity, has been linked to a significantly higher risk of cardiovascular issues in a recent study. Experts advise caution, medical supervision, and emphasise that IF is not a one-size-fits-all solution
• Is two pegs of alcohol good for your heart? Here’s what experts say. Read on to know what experts think of alcohol consumption, the risks behind it and debunking popular myths about its purported benefits

🎉Have news to share? Publish a press release on FemTech India to reach industry-leading executives, investors, and passionate individuals.

See you next Friday, friends 👋
Navneet

[Sign up here to never miss on the latest updates.]